drugset / Trial / NCT05783479
Pharmacological Preparation of the Cervix for Hysteroscopy
Non-randomizedParallel-groupOpen-labelTreatment
Summary
Pain accompanying office hysteroscopy is the most common reason for its discontinuation. Urogenital atrophy may cause technical difficulties in passage through the cervical canal, further increasing the pain. The aim was to evaluate the effectiveness of vaginal estradiol and hyaluronic acid to facilitate diagnostic hysteroscopy in peri- and postmenopausal women.
Timeline
- Start
- 2022-06-01
- Primary completion
- 2022-12-30
- Completion
- 2023-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Estradiol | Other / unclassified | 0.5 mg | Other |
| Comparator | Hyaluronic Acid | Other / unclassified | 5 mg | Other |